DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Liu Q, Bethune C, Dessouki E. et al.
ISIS-FXIRx, a novel and specific antisense inhibitor of factor XI, caused significant reduction in FXI antigen and activity and increased aPTT without causing bleeding in healthy volunteers.
Blood 2011;
118: 209
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.